Post by Stefan König

Global CEO Merz Therapeutics | Innovative Treatment Standards | Partnerships in Healthcare

Our team participated in the 7th World Parkinson Congress in Phoenix, where scientific data were presented as part of the ongoing exchange in Parkinson’s disease research. This year’s strong focus on patient-reported outcomes in protocol-based research strongly reinforces what guides our work at Merz Therapeutics: the true value of any treatment lies in how it improves daily life for people living with Parkinson's. When patients, caregivers, clinicians and researchers come together with a shared mission, the impact is extraordinary. Thank you to our research teams and to Stefan-Alexander Albrecht for his leadership in advancing how we can translate science into progress for people living with Parkinson’s. #MerzTx #WPC2026 #BetterOutcomesforMorePatients

Post contentPost content